Cite
MLA Citation
Hanna Lythgoe et al.. “Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma.” Rheumatology, vol. 57, 2018, pp. 398–401. http://access.bl.uk/ark:/81055/vdc_100095475306.0x00001c